Announcement: Introducing Investing in Longevity 101 course launch -- navigating the emerging field of longevity
Deep Longevity Ltd
image: Introducing Investing in Longevity 101 Course Launch- Navigating the Emerging Field of Longevity view more
Credit: Longevity Education Hub
The wait is over! The new course, Investing in Longevity 101, is now ready to assist in navigating the transformative industry of longevity. The industry is set to revolutionize the world, presenting both challenges and remarkable opportunities for investors and participants alike.
Investing in a new mega-trend can be daunting, as entering an unfamiliar market requires a comprehensive understanding of new terminologies, scientific advancements, risks, and potential opportunities. Investing in Longevity 101 is designed to address these needs.
The online course is tailored to cater to a diverse audience of venture capitalists, fund managers, angel investors, pharma executives & biotechnology professionals, medical doctors pursuing continuing medical education, entrepreneurs, medical students, scientists, etc. The course welcomes all those eager to explore the potential of longevity and is part of a series of longevity education courses launched by Longevity Education Hub.
In today's landscape, there are companies such as supplement manufacturers, clinics, and biomarker vendors already generating revenues and raising capital. Additionally, numerous longevity biotechs are progressing through clinical trial phases, with an increasing number reaching human trials. Countless other companies are not far behind, actively seeking significant investments to sustain their progress and expedite their journey to the clinic or market. Education is the key to unlocking the vast potential of longevity. By truly understanding this dynamic field, investors can benefit from its incredible opportunities while contributing much-needed investments to the longevity sector.
The course founders, Evelyne Bischof, Longevity Physician and Professor of medicine, Phil Newman, Founder & CEO of Longevity.Technology, Ricardo Gaminha Pacheco, Physician Executive - Pharma & Biotech, Jiayi Song, Finance and Economics Specialist, and Alex Zhavoronkov, PhD, CEO of Insilico Medicine and course founder, have shed more light on its content around a virtual table.
Phil Newman, CEO of Longevity.Technology and one of the course's founders, stated, "Whether individuals are interested in 'longevity now' or 'longevity next,' risks and rewards will always be present for investors. That's precisely why Investing in Longevity 101 is so essential. The longevity economy is gaining momentum, and our aim is to provide investors and those seeking investment with a solid knowledge foundation to thrive."
Alex Zhavoronkov, PhD, CEO of Insilico Medicine and course founder, emphasized, "Investing is a risky business, and the cost of bringing a single drug to market can reach $2 billion. The cost, time, and failure rate in longevity biotechnology are likely to be even higher. Currently, there are no success stories in longevity biotechnology. Understanding when to deploy capital is crucial for investors, as hype cycles in longevity often align with macroeconomic trends."
Jiayi Song, Finance and Economics Specialist, stated, “We are thrilled to announce our commitment to longevity venture capital, a transformative field with immense potential to reshape the future of human longevity. With this strategic focus, we aim to identify pioneering companies and breakthrough technologies that will extend and enhance the quality of human life. Our dedication to longevity venture capital underscores our firm belief to create a world where people can live more fulfilling lives.”
Evelyne Bischof, Longevity Physician and Professor of medicine highlighted, "Embracing the horizon of investing in longevity, venture capitalists embark on a noble journey, where they not only seek financial returns but also champion breakthrough developments, fostering a future where extended lifespans unfold alongside profound human healthspan optimization. We aimed to provide a small overview of the landscape based on selected examples".
Don't miss this opportunity to gain valuable insights into the burgeoning field of longevity and equip oneself with the knowledge needed to seize its immense potential. Invest in the future by investing in longevity with Investing in Longevity 101!
Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.